In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

Novel conditionally active T cell engagers sourced from proprietary BiTAC® platform are at the basis of advanced partnering initiatives and development activitiesZURICH, SWITZERLAND – July 6, 2026 -- ...

As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...

German engineering company GEA is relocating its Application and Technology Center for future food from Hildesheim to ...

Novartis has acquired UK biotech Myricx for up to $1.5bn as global drugmakers invest inpromising biotech firms ahead expected ...

A biotech startup and an aerospace startup said their moves to Colorado were based on lifestyle issues and the state’s ...

Novartis AG NVS has agreed to acquire privately held U.K. biotechnology company Myricx Bio in a deal valued at up to $1.5 ...

The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...

Novartis is buying Myricx to internalize an NMTi-based ADC payload platform intended to expand ADC applicability and ...

AI architect and supply chain expert Vineel Mouli Natakam is transforming pharmaceutical logistics with intelligent, ...

In a note dated Monday, the brokerage said hyperscalers — an industry term for tech companies that are spending big on data ...

Transparency and intellectual property are crucial when it concerns money being spent towards public interest.